Press Room


    Press Release - September 30, 2009

    Sernova To Present Research Results At Leading International Islet Transplant Conference

    London, Ontario - September 30, 2009 - Sernova Corp. (TSX-V: SVA) is pleased to announce that the company has accepted an invitation to present scientific results from its islet transplantation studies using its Cell Pouch SystemTM at a joint conference of the International Pancreas and Islet Transplant Association and the International Xenotransplantation Association to be held in Venice, Italy from October 12 - 16.

    Dr. David White, Chairman of Sernova's Scientific Advisory Board, said "We are very pleased to receive the recognition afforded by this important invitation to present our research to the international scientific community. This international conference is an excellent opportunity to explain the virtues of the Sernova Cell Pouch SystemTM, which provides a biocompatible chamber which eliminates many of the current issues with the standard of treatment related to injection of cells into the body"

    The conference will bring together the most eminent scientists and clinicians in the cell transplantation field from around the world. Sernova will be presenting seven abstracts, three of which will be highlighted in podium presentations, creating an excellent venue to discuss the novel and important aspects of Sernova's revolutionary approach to cellular therapies, such as islet cell transplantation for diabetes.

    Sernova will provide additional information on presentation times as well as study results as the conference proceeds.

    About Sernova Sernova Corp. is a Canadian-based, health- sciences company focused on commercializing medical technologies. Sernova is currently developing a platform technology for a number of serious disease indications, starting with a novel treatment for insulin- dependent diabetes, using the novel Cell Pouch SystemTM and its patented SertolinTM cell technology. According to the American Diabetes Association approximately 9 million Americans require insulin injections and it is the sixth leading cause of death in the United States. One out of every 8 dollars spent on health care in the United States is spent on treating diabetes and its complications. Worldwide expenditures on insulin alone are estimated to be $15 billion annually and growing.

    This news release may contain forward-looking statements. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements.

    For further information contact: Philip Toleikis, Ph.D., President and CEO Tel: (604) 961-2939; email:; website:



    Press Releases from:

    2018 2017 2016 2015 2014 2013 2012

    2011 2010 2009 2008 2007 2006 2005

    2004 2003 2002 2001 2000 1999

    Featured News

    2014, January 22

    Sernova’s Disruptive Regenerative Medicine Technologies Set to Improve the Treatment of Chronic Diseases While Reducing Healthcare Costs


    2012, July 11

    Sernova Corp. developing a tiered approach to the treatment of diabetes

    Publisher: Canadian Investor Magazine
    Author: Rochelle Emnance


    2012, July 30

    Feds back local diabetes discovery

    Publisher: London Free Press
    Author: Norman De Bono

    2012, July 30

    Federal program pumps $3 million into new, London business

    Publisher: The London Free Press

    Author: Norman De Bono

    2010 July 10

    Canada's economic action plan supports business innovators

    Publisher: Federal Economic Development Agency for Southern Ontario


    2007, February 20

    "Transplanted cells may protect against diabetes without forced drug use: An interview with Dr. David White"

    Author: Julie Ickes and James Finch

    2006, October 04

    "Sertoli Cells: Mother nature's anti-rejection drug"

    Author: James Finch

    2006, August 24

    "Mass marketing diabetes reversal; novel xeno-transplants may offer new hope for type 1 diabetics"

    Author: James Finch

    Presentation and Video

    May 03, 2018

    Corporate Presentation

    April 2018

    March 29, 2018

    2018 Financial Report - 1st Quarter

    March 29, 2018

    2018 Management Discussion & Analysis (MD&A) - 1st Quarter

    December 11, 2017

    Clearance by FDA of Sernova's US IND

    Conference call audio recording

    September 11, 2017

    Sernova Fact Sheet

    Subscribe to Sernova News